145 related articles for article (PubMed ID: 9027929)
1. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
[TBL] [Abstract][Full Text] [Related]
2. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
[TBL] [Abstract][Full Text] [Related]
5. Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.
Tan PZ; Baldwin RM; Van Dyck CH; Al-Tikriti M; Roth B; Khan N; Charney DS; Innis RB
Nucl Med Biol; 1999 Aug; 26(6):601-8. PubMed ID: 10587097
[TBL] [Abstract][Full Text] [Related]
6. PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin.
van Dyck CH; Tan PZ; Baldwin RM; Amici LA; Garg PK; Ng CK; Soufer R; Charney DS; Innis RB
J Nucl Med; 2000 Feb; 41(2):234-41. PubMed ID: 10688105
[TBL] [Abstract][Full Text] [Related]
7. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
[TBL] [Abstract][Full Text] [Related]
8. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
[TBL] [Abstract][Full Text] [Related]
9. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.
Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF
Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399
[TBL] [Abstract][Full Text] [Related]
10. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH
Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474
[TBL] [Abstract][Full Text] [Related]
11. Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
Kristiansen H; Elfving B; Plenge P; Pinborg LH; Gillings N; Knudsen GM
Synapse; 2005 Dec; 58(4):249-57. PubMed ID: 16206185
[TBL] [Abstract][Full Text] [Related]
12. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.
Pinborg LH; Adams KH; Svarer C; Holm S; Hasselbalch SG; Haugbøl S; Madsen J; Knudsen GM
J Cereb Blood Flow Metab; 2003 Aug; 23(8):985-96. PubMed ID: 12902843
[TBL] [Abstract][Full Text] [Related]
13. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
[TBL] [Abstract][Full Text] [Related]
15. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation.
Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM
Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894
[TBL] [Abstract][Full Text] [Related]
16. Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.
Kroll T; Elmenhorst D; Matusch A; Wedekind F; Weisshaupt A; Beer S; Bauer A
Mol Imaging Biol; 2013 Aug; 15(4):456-67. PubMed ID: 23456885
[TBL] [Abstract][Full Text] [Related]
17. In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study.
Biver F; Lotstra F; Monclus M; Dethy S; Damhaut P; Wikler D; Luxen A; Goldman S
Nucl Med Biol; 1997 May; 24(4):357-60. PubMed ID: 9257335
[TBL] [Abstract][Full Text] [Related]
18. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
van Dyck CH; Soares JC; Tan PZ; Staley JK; Baldwin RM; Amici LA; Fu X; Garg PK; Seibyl JP; Charney DS; Innis RB
Nucl Med Biol; 2000 Nov; 27(8):715-22. PubMed ID: 11150702
[TBL] [Abstract][Full Text] [Related]
19. Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortem.
Forutan F; Estalji S; Beu M; Nikolaus S; Hamacher K; Coenen HH; Vosberg H; Müller-Gärtner HW; Larisch R
Nuklearmedizin; 2002; 41(4):197-201. PubMed ID: 12224404
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain.
Andrée B; Nyberg S; Ito H; Ginovart N; Brunner F; Jaquet F; Halldin C; Farde L
J Clin Psychopharmacol; 1998 Aug; 18(4):317-23. PubMed ID: 9690698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
